# Nanoparticle Drug Delivery Modeling and Optimization

## 1. Project Objective

This project developed a computational model to predict cumulative drug release from polymeric nanoparticles and investigate how nanoparticle and environmental parameters affect drug-release behavior.

The model evaluates the effects of:

- Nanoparticle radius
- Temperature
- Environmental pH
- Polymer degradation rate

The final model was calibrated against experimental drug-release data and used for sensitivity analysis and optimization.

## 2. Model Development

Three model versions were developed progressively.

Version 3 incorporated calibration of the diffusion scaling behavior and produced substantially improved agreement with the experimental data compared with earlier model versions.

## 3. Model Validation

The Version 3 model was compared against experimental measurements at 0, 1, 24, 48, and 72 hours.

The validation results were:

- RMSE: 7.144 percentage points
- MAE: 4.452 percentage points
- R²: 0.9610

The R² value indicates a strong agreement between the calibrated model and the experimental release profile.

## 4. Sensitivity Analysis

### Nanoparticle Radius

Increasing nanoparticle radius increased the predicted release time. Larger nanoparticles therefore produced slower drug release within the modeled system.

### Temperature

Increasing temperature decreased both t50 and t90. Higher temperature therefore accelerated the predicted drug-release process.

### Environmental pH

Increasing environmental pH decreased the predicted release times. The model therefore indicates that pH is an important environmental parameter affecting release behavior.

### Polymer Degradation

Increasing polymer degradation rate decreased both t50 and t90. Faster polymer degradation therefore resulted in faster predicted drug release.

## 5. Optimization

The optimization analysis identified the following lowest-error configuration:

| Parameter | Optimized Value |
|---|---:|
| Nanoparticle radius | 200 nm |
| Temperature | 30 °C |
| Environmental pH | 7.0 |
| Polymer degradation rate | 0.005 1/hour |
| Predicted t50 | 13.83 hours |
| Predicted t90 | 35.07 hours |
| Optimization error | 4.205 |

This configuration represents the model's best-performing parameter combination based on the optimization objective.

## 6. Engineering Interpretation

The results demonstrate that nanoparticle drug release is strongly dependent on particle size, temperature, environmental pH, and polymer degradation.

The sensitivity analyses provide a framework for understanding how these parameters can be adjusted to control drug-release timing.

The calibrated Version 3 model provides a substantially better representation of the experimental data than the earlier model versions.

## 7. Limitations

The model is a computational representation of nanoparticle drug release and should not be interpreted as experimental or clinical validation.

Additional experimental data would be required to determine how well the model generalizes to different nanoparticle materials, drug-loading levels, polymer compositions, and biological environments.

## 8. Conclusion

A computational nanoparticle drug-delivery model was developed, calibrated, validated, and optimized.

Version 3 achieved an R² of 0.9610, demonstrating strong agreement with the available experimental release data.

Sensitivity analysis showed that nanoparticle radius, temperature, environmental pH, and polymer degradation rate can substantially influence predicted drug-release timing.

The optimization identified a 200 nm nanoparticle at 30 °C, pH 7.0, and a polymer degradation rate of 0.005 1/hour as the lowest-error configuration within the tested parameter space.

Overall, the project demonstrates how computational modeling, sensitivity analysis, calibration, and optimization can be combined to investigate and predict controlled nanoparticle drug release.